Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)
China · Delayed Price · Currency is CNY 20.36
+0.39 (1.95%)
At close: Sep 5, 2025
Huaxia Eye Hospital Group Revenue
Huaxia Eye Hospital Group had revenue of 1.05B CNY in the quarter ending June 30, 2025, a decrease of -2.47%. This brings the company's revenue in the last twelve months to 4.12B, up 1.12% year-over-year. In the year 2024, Huaxia Eye Hospital Group had annual revenue of 4.03B with 0.35% growth.
Revenue (ttm)
4.12B
Revenue Growth
+1.12%
P/S Ratio
4.12
Revenue / Employee
522.06K
Employees
7,883
Market Cap
16.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.03B | 13.85M | 0.35% |
| Dec 31, 2023 | 4.01B | 779.92M | 24.12% |
| Jan 1, 2023 | 3.23B | 168.81M | 5.51% |
| Jan 1, 2022 | 3.06B | 549.77M | 21.86% |
| Dec 31, 2020 | 2.51B | 58.28M | 2.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |